Long COVID: major findings, mechanisms and recommendations

Nature reviews: microbiology
13 January 2023
https://www.nature.com/articles/s41579-022-00846-2

Clinicians Discuss Major Treatments for Long COVID–The Effective and the Questionable

The Epoch Times
02 January 2023
https://www.theepochtimes.com/health/clinicians-discuss-major-treatments-for-long-covid-the-effective-and-the-questionable_4950709.html

Researchers launch trial to treat long COVID with drug used to block effects of opioids

ABC Gold Coast
20 December 2022
https://www.abc.net.au/news/2022-12-21/long-covid-treatment-trial-drug-low-dose-naltrexone/101770626?utm_source=abc_news_web&utm_medium=content_shared&utm_campaign=abc_news_web

‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever

Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever

LDN for Treating Spike Protein Injuries, Diseases

Epoch Health
26 October 2022
https://www.theepochtimes.com/health/low-dose-naltrexone-for-long-covid-and-spike-induced-injuries_4820584.html

Addiction drug shows promise lifting long COVID brain fog, fatigue

Reuters
18 October 2022
https://www.reuters.com/business/healthcare-pharmaceuticals/addiction-drug-shows-promise-lifting-long-covid-brain-fog-fatigue-2022-10-18/

Linda: Welcome to the LDN radio show brought to you by the LDN Research Trust. I'm your host Linda Elsegood.  I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining us.

The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details

Low Dose Naltrexone (LDN) Provides Surprising Pain Relief

The People's Pharmacy
18 August 2022
https://www.peoplespharmacy.com/articles/low-dose-naltrexone-ldn-provides-surprising-pain-relief